Similar articles

• [Management of hypertensive patients with cardiovascular damage].

  Tomiyama H, Takata Y, Yamashina A. Tomiyama H, et al. Nihon Rinsho. 2004 Mar;62 Suppl 3:612-6. Nihon Rinsho. 2004. PMID: 15171444 Review. Japanese. No abstract available.
• [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2002 Sep 19;144(38):14. MMW Fortschr Med. 2002. PMID: 12395694 German. No abstract available.
• [Results from the LIFE study: promising effects of new hypertensive agents].

  Nilsson P, Kahan T. Nilsson P, et al. Lakartidningen. 2002 Apr 18;99(16):1792-4. Lakartidningen. 2002. PMID: 12043477 Review. Swedish. No abstract available.
• [Hypertension plus left ventricular hypertrophy. Prognosis can now be significantly improved].

  Einecke D. Einecke D. MMW Fortschr Med. 2002 Apr 4;144(14):4-5. MMW Fortschr Med. 2002. PMID: 12014276 German. No abstract available.
• [What are the consequences of the LIFE Study for general practice].

  Zidek W. Zidek W. MMW Fortschr Med. 2002 Sep 19;144(38):48. MMW Fortschr Med. 2002. PMID: 12395704 German. No abstract available.